Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines

Cancer Science

Volumn 101, Issue 10, 2010, Pages 2145-2155

  Kimura, Osamu ^a   Takahashi, Takeshi ^a   Ishii, Naoto ^a   Inoue, Yuki ^a   Ueno, Yoshiyuki ^a   Kogure, Takayuki ^a   Fukushima, Koji ^a   Shiina, Masaaki ^a   Yamagiwa, Yoko ^a   Kondo, Yasuteru ^a   Inoue, Jun ^a   Kakazu, Eiji ^a   Iwasaki, Takao ^a   Kawagishi, Naoki ^a   Shimosegawa, Tooru ^a   Sugamura, Kazuo ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyagi Cancer Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL CLONE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CANCER STEM CELL; CHEMISTRY; GENETICS; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; MICE; NEOPLASTIC STEM CELLS; PROTEIN STRUCTURE, TERTIARY;

EID: 77957051282     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01661.x     Document Type: Article

References (46)

1. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008, 7:237-57.
2. Hotte SJ, Hirte HW. BAY 43-9006: early clinical data in patients with advanced solid malignancies. Curr Pharm Des 2002, 8:2249-53.
3. Kane RC, Farrell AT, Madabushi R. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Oncologist 2009, 14:95-100.
4. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008, 134:1752-63.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70.
6. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-7.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-8.
8. Singh SK, Clarke ID, Terasaki M. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-8.
9. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene 2004, 23:7267-73.
10. Singh SK, Hawkins C, Clarke ID. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
11. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-10.
12. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004, 23:7274-82.
13. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-68.
14. Guan Y, Gerhard B, Hogge DE. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 2003, 101:3142-9.
15. Guzman ML, Swiderski CF, Howard DS. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 2002, 99:16220-5.
16. Chiba T, Kita K, Zheng YW. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-51.
17. Lee JS, Heo J, Libbrecht L. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006, 12:410-16.
18. Ma S, Chan KW, Hu L. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-56.
19. Yang ZF, Ho DW, Ng MN. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-66.
20. Yamashita T, Forgues M, Wang W. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 2008, 68:1451-61.
21. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999, 77:699-712.
22. Osta WA, Chen Y, Mikhitarian K. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004, 64:5818-24.
23. Li C, Heidt DG, Dalerba P. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-7.
24. Watanabe Y, Takahashi T, Okajima A. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 2009, 21:843-58.
25. Ito M, Hiramatsu H, Kobayashi K. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-82.
26. Ishikawa F, Yasukawa M, Lyons B. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565-73.
27. Machida K, Suemizu H, Kawai K. Higher susceptibility of NOG mice to xenotransplanted tumors. J Toxicol Sci 2009, 34:123-7.
28. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-8.
29. Yamazaki H, Nishida H, Iwata S, Dang NH, Morimoto C. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. Biochem Biophys Res Commun 2009, 383:172-7.
30. Yamashita T, Ji J, Budhu A. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-24.
31. Hirohashi S, Shimosato Y, Kameya T. Production of alpha-fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology. Cancer Res 1979, 39:1819-28.
32. Alexander J, Bey E, Whitcutt JM, Gear JH. Adaptation of cells derived from human malignant tumours to growth in vitro. S Afr J Med Sci 1976, 41:89-98.
33. Kogure T, Ueno Y, Iwasaki T, Shimosegawa T. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors. Cancer Chemother Pharmacol 2004, 53:296-304.
34. Zhou J, Yu Z, Zhao S. Lentivirus-Based DsRed-2-Transfected Pancreatic Cancer Cells for Deep In Vivo Imaging of Metastatic Disease. J Surg Res 2009, 157:63-70.
35. Yang ZF, Ngai P, Ho DW. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008, 47:919-28.
36. Yin S, Li J, Hu C. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007, 120:1444-50.
37. Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008, 27:1749-58.
38. Zen Y, Fujii T, Yoshikawa S. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol 2007, 170:1750-62.
39. Chiba T, Zheng YW, Kita K. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 2007, 133:937-50.
40. Schmelzer E, Zhang L, Bruce A. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007, 204:1973-87.
41. Rao MS, Khan AA, Parveen N, Habeeb MA, Habibullah CM, Pande G. Characterization of hepatic progenitors from human fetal liver during second trimester. World J Gastroenterol 2008, 14:5730-7.
42. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008, 10:R25.
43. Yamashita T, Budhu A, Forgues M, Wang XW. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res 2007, 67:10831-9.
44. Maetzel D, Denzel S, Mack B. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009, 11:162-71.
45. Yoo BK, Emdad L, Su ZZ. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009, 119:465-77.
46. Tirino V, Desiderio V, d'Aquino R. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS ONE 2008, 3:e3469.